跳至主要内容
临床试验/NCT02472951
NCT02472951已完成不适用

Cut Down on Carbohydrate Usage in the Diet of Type 2 Diabetes - Mechanisms of Effective Therapy of Diabetes by Selective Choice of Macronutrients - The Phenotype Study

Bispebjerg Hospital2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2015年8月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
2
主要终点
Insulin sensitivity

研究概览

简要总结

Scientific evidence for the dietary treatment of type 2 diabetes is insufficient. The investigators hypothesize that a lower carbohydrate content in the diabetic diet than the recommended 55 E% will decrease the postprandial glucose excursion, decrease insulinotropic factors like incretin hormones and decrease their insulinotropic effects due to their glucose dependency. This will reduce postprandial insulin concentration, resulting in an improved insulin sensitivity and glucose metabolism. This clinical study will examine in diabetic, prediabetic and healthy subjects the acute effects of short term highly controlled dietary low carbohydrate intervention on metabolic pathways with respect to insulin action, pancreatic islet function, lipid metabolism, incretin hormones, low grade inflammation in plasma and novel measures of fatty acid metabolism.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men age 18-70 years
  • Postmenopausal women age 55-70 years
  • Non-smoker (abstinent at least 6 months)
  • HbA1c < 74 mmol/mol
  • Fasting blood glucose < 11 mmol/L (mean of 3 measurements)
  • Negative (<25 IU/L) plasma glutamate decarboxylase (GAD-65) antibodies (IgG)
  • Hemoglobin > 7.5 mmol/L (men); > 6.8 mmol/L (women)
  • Normal thrombocytes (140-400 x 109/L)
  • eGFR > 45 ml/min per 1.73 m2
  • Alkaline phosphatase < 140 IU/L
  • Alanine aminotransferase < 70 IU/L
  • Normal International Normalized Ratio (0.9-1.2)

排除标准

  • Critical illness
  • Anti-diabetic drugs other than metformin (maximum of 2000 mg / day)
  • Steroid treatment e.g. prednisolone
  • Reported or journalized severe food allergy or intolerance
  • Reported or journalized gut disease e.g. Crohn's disease, Coeliac disease
  • Reported or journalized alcohol dependence syndrome

研究组 & 干预措施

Type 2 diabetic subjects

Active Comparator

干预措施: Low carbohydrate meals (Other)

Type 2 diabetic subjects

Active Comparator

干预措施: Standard carbohydrate meals (Other)

Prediabetic subjects

Active Comparator

干预措施: Low carbohydrate meals (Other)

Prediabetic subjects

Active Comparator

干预措施: Standard carbohydrate meals (Other)

Healthy subjects

Active Comparator

干预措施: Low carbohydrate meals (Other)

Healthy subjects

Active Comparator

干预措施: Standard carbohydrate meals (Other)

结局指标

主要结局

Insulin sensitivity

时间窗: Measured during meal tests (2 days with each intervention)

Insulin sensitivity as measured by the oral minimal model applied to the meal test

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amirsalar Samkani

MD, PhD-stud

Bispebjerg Hospital

研究点 (2)

Loading locations...

相似试验

Cut Down on Carbohydrate Usage in the Diet of Type 2... | 临床试验